Pathogenesis and Preventive Tactics of Immune-Mediated Non-Pulmonary COVID-19 in Children and Beyond

Int J Mol Sci. 2022 Nov 16;23(22):14157. doi: 10.3390/ijms232214157.

Abstract

The COVID-19 pandemic has evolved to immune escape and threatened small children and the elderly with a higher severity and fatality of non-pulmonary diseases. These life-threatening non-pulmonary COVID-19 diseases such as acute necrotizing encephalopathies (ANE) and multisystem inflammatory syndrome in children (MIS-C) are more prevalent in children. However, the mortality of multisystem inflammatory syndrome in adults (MIS-A) is much higher than that of MIS-C although the incidence of MIS-A is lower. Clarification of immunopathogenesis and genetic susceptibility of inflammatory non-pulmonary COVID-19 diseases would provide an appropriate guide for the crisis management and prevention of morbidity and fatality in the ongoing pandemic. This review article described three inflammatory non-pulmonary COVID-19 diseases including (1) meningoencephalitis (ME), (2) acute necrotizing encephalopathies (ANE), and (3) post-infectious multisystem inflammatory syndrome in children (MIS-C) and in adults (MIS-A). To prevent these life-threatening non-pulmonary COVID-19 diseases, hosts carrying susceptible genetic variants should receive prophylactic vaccines, avoid febrile respiratory tract infection, and institute immunomodulators and mitochondrial cocktails as early as possible.

Keywords: acute necrotizing encephalopathy (ANE); coronavirus disease 2019 (COVID-19); immunopathogenesis; meningoencephalitis (ME); multisystem inflammatory syndrome in children (MIS-C); non-pulmonary COVID-19.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Brain Diseases*
  • COVID-19*
  • Child
  • Humans
  • Pandemics

Supplementary concepts

  • adult multisystem inflammatory disease, COVID-19 related
  • pediatric multisystem inflammatory disease, COVID-19 related